Andreas Norlin

Andreas Norlin (born 1970) has 20+ years of experience in research, preclinical- and clinical-stage drug development within e.g., oncology, inflammatory disease, and diabetes. During the most recent years before joining Ascelia, Andreas had strategic executive roles in several biotech start-up companies in the Greater Copenhagen area. Before that, he served as Project Vice President and held other development project leadership positions at Novo Nordisk, Denmark. Andreas started his career with various positions in preclinical R&D at Camurus AB, Sweden.

Andreas joined Ascelia Pharma in 2020 and became a member of the Management Team in 2022.